Artiva Biotherapeutics, Inc. Common Stock
Symbol: ARTV (NASDAQ)
2.72
▲ (0.89%) 0.024
Company Description:
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
Key Stats
- Today's Open: $2.7
- Today's High: $2.755
- Today's Low: $2.555
- Today's Volume: 188.83K
- Yesterday Close: $2.7
- Yesterday High: $2.845
- Yesterday Low: $2.65
- Yesterday Volume: 48.59K
- Last Min Volume: 0
- Last Min High: $2.724
- Last Min Low: $2.704
- Last Min VWAP: $0
Company Profile
- Name: Artiva Biotherapeutics, Inc. Common Stock
- Website: https://www.artivabio.com
- Listed Date: 2024-07-19
- Location: SAN DIEGO, CA
- Market Status: Active
- CIK Number: 0001817241
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $65.95M
- Round Lot: 100
- Outstanding Shares: 24.43M
- Asset Type: CS
RECENT FILINGS FOR ARTV
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-18 | 4 | View |
| 2025-08-18 | 4 | View |
| 2025-08-18 | 4 | View |
| 2025-08-18 | 4 | View |
| 2025-08-18 | 4 | View |
| 2025-08-15 | EFFECT | View |
| 2025-08-15 | 144 | View |
| 2025-08-06 | S-3 | View |
| 2025-08-06 | S-8 | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-07-16 | SCHEDULE 13G/A | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-25 | 8-K | View |
Latest News on ARTV